Oxford R21/Matrix-M™ malaria vaccine receives regulatory clearance for use in Burkina Faso

Published on July 24, 2023

The University of Oxford-developed, Serum Institute of India PvT Ltd (SIIPL) manufactured and scaled up R21/Matrix-MTM malaria vaccine, leveraging Novavax’s adjuvant technology, has been licensed for use in Burkina Faso by the country’s regulatory agency, Agence Nationale de la Regulation Pharmaceutique (ANRP).
Continue reading on website
Other news

Science Together celebrates a second successful year of community-led research collaborations

July 21, 2023
Last week, the University of Oxford’s historic Divinity School hosted a special evening event to celebrate the seven new community-led research collaborations formed over the last 12 months through the Science Together engagement programme.

Researchers successfully train a machine learning model in outer space for the first time

July 27, 2023
For the first time, researchers have trained a machine learning model in outer space, on board a satellite. This achievement could enable real-time monitoring and decision making for a range of applications, from disaster management to deforestation.